UBS Group
CLBTW

UBS Group’s Cellebrite DI Ltd. Warrants CLBTW Stock Holding History

UBS Group’s Portfolio CLBTW Stock Details CLBTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-43
Closed -$92 – 10299
2024
Q1 		$92 Sell
43
-967
-96% -$1.91K ﹤0.01% 8849
2023
Q4 		$1.39K Buy
+1,010
New +$1.19K ﹤0.01% 8315
2023
Q2 		– Sell
-3,900
Closed -$3.35K – 9916
2023
Q1 		$3.35K Sell
3,900
-6,920
-64% -$5.86K ﹤0.01% 8333
2022
Q4 		$6.71K Buy
+10,820
New +$7.25K ﹤0.01% 8994
2022
Q1 		– Sell
-1,265
Closed -$2K – 11093
2021
Q4 		$2K Buy
+1,265
New +$2.8K ﹤0.01% 9853

Other funds holding CLBTW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

UBS Group's CLBTW Position: Q2 2024 in Review

UBS Group sold out of Cellebrite DI Ltd. Warrants (CLBTW) in Q2 2024, closing a stake of 43 shares — an estimated $92 sold.

UBS Group first reported a position in CLBTW in Q4 2021 and held it in 5 quarters. The position peaked at $6.71K in Q4 2022. 19 funds tracked by Wall St. Rank hold CLBTW as of Q2 2024.

  • UBS Group reported no remaining Cellebrite DI Ltd. Warrants position as of Q2 2024 after selling out during the quarter.
  • UBS Group sold 43 Cellebrite DI Ltd. Warrants shares in Q2 2024, an estimated $92.
  • UBS Group first reported a position in Cellebrite DI Ltd. Warrants in Q4 2021 and held it in 5 quarters.
  • UBS Group's Cellebrite DI Ltd. Warrants position peaked at $6.71K in Q4 2022.
  • 19 funds tracked by Wall St. Rank held Cellebrite DI Ltd. Warrants as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.